US Cannabis Stocks Boosted by Milestone Research Law

Dec.07.2022
US Cannabis Stocks Boosted by Milestone Research Law
US bill expands marijuana research, boosting cannabis stocks. It makes it easier for scientists to study the plant.

Following the signing of a landmark bill by US President Joe Biden, cannabis stocks received a boost on Friday as the bill expands marijuana research.


The bipartisan Medical Marijuana and Cannabinoid Research Expansion Act has made it easier for scientists to study this plant by streamlining the application process for approving cannabis-related scientific research and allowing researchers to grow or import marijuana for medical research purposes.


This directs the Department of Health and Human Services (DHHS) to investigate policies prohibiting research on marijuana and provide recommendations on how to eliminate these barriers. It also directs DHHS to research the therapeutic potential of marijuana.


This occurred after President Biden requested a review of the status of marijuana as a Schedule I substance under the Controlled Substances Act in October. It has been reported that the Secure and Fair Enforcement (SAFE) Banking Act will protect banks and other financial institutions from being penalized for providing services to legally-operating cannabis-related businesses, and may be passed by the end of the year.


On Monday morning, US cannabis stocks experienced a surge in response to news updates. Australis Capital Inc (CSE:AUSA, OTCQB:AUSAF) saw a rise of 15%, Planet 13 Holdings Inc (CSE:PLTH, OTCQX:PLNHF) increased by 5.6%, Jushi Holdings Inc (CSE:JUSH, OTCQX:JUSHF) rose by 6.8%, Delta 9 Cannabis Inc (TSX:DN) went up by 4.2%, and FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) saw a 2.8% rise.


The stocks of Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc rose by 2%, Avikana Inc (TSX:AVCN, OTCQX:AVCNF) by 2.7%, Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) by 4%, and Nextleaf Solutions Ltd (CSE:OILS, OTCQB:OILFF) by 0.8%.


2FIRSTS will continue to track and report on this topic, with future updates available on the '2FIRSTSAPP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK E-Cigarette Stores Report: Smokers Switching to E-Cigarettes Could Save Over £2,400 Annually
UK E-Cigarette Stores Report: Smokers Switching to E-Cigarettes Could Save Over £2,400 Annually
New data from the UK online vape store 'Vape Superstore' reveals that smokers switching to e-cigarettes can save a significant amount annually. The average annual cost of smoking is £2,920 (around $3,882), while e-cigarettes cost £480 (around $638) per year, leading to savings of £2,440 (around $3,243) annually.
Aug.04 by 2FIRSTS.ai
UK MHRA Reports 193 e-cigarette SKUs, Including Brands VAPORESSO, IJOY, ALD, ASPIRE, HAYATI, SMOK
UK MHRA Reports 193 e-cigarette SKUs, Including Brands VAPORESSO, IJOY, ALD, ASPIRE, HAYATI, SMOK
MHRA database reveals 193 e-cigarette SKUs in the UK market from brands like VAPORESSO, IJOY, ALD, and SMOK.
Aug.28 by 2FIRSTS.ai
The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
On August 22, the U.S. FDA issued two notices soliciting public comments on regulations regarding tobacco retailer training programs and restrictions on tobacco sales. Both notices provide a 60-day public comment period under the Paperwork Reduction Act, aiming to protect public health, especially that of children and adolescents, by regulating retailer behavior and restricting tobacco sales.
Aug.22 by 2FIRSTS.ai
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT reported H1 2025 revenue of £12.07 billion, down 2.2% due to FX, but up 1.8% at constant rates. Smoke-free products made up 18.2% of total revenue, with Velo sales rising 40.6%. BAT maintained its full-year outlook and raised its 2025 share buyback to £1.1 billion.
Jul.31 by 2FIRSTS.ai
Imperial Tobacco Canada Seeks U.S. Recognition of $23.6 Billion Restructuring and Settlement Plan
Imperial Tobacco Canada Seeks U.S. Recognition of $23.6 Billion Restructuring and Settlement Plan
Tobacco giant Imperial Tobacco Canada seeks US court approval for $23.59 billion restructuring plan to settle lawsuits.
Aug.07 by 2FIRSTS.ai
Interview: AIRSCREAM on Balancing Compliance and Market Demand Amid the Disposable Vape Crackdown
Interview: AIRSCREAM on Balancing Compliance and Market Demand Amid the Disposable Vape Crackdown
During the Dubai World Vape Show, AIRSCREAM executive Andrew spoke with 2Firsts about the brand’s strategies on compliance, large-capacity products, and nicotine alternatives. He underscored the company’s stance against disposable vapes and its commitment to long-termism and youth protection.
Jul.04